These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37652681)

  • 1. Household secondary attack rates and risk factors during periods of SARS-CoV-2 Delta and Omicron variant predominance in the Republic of Korea.
    Lee J; Ko M; Kim S; Lim D; Park G; Lee SE
    Osong Public Health Res Perspect; 2023 Aug; 14(4):263-271. PubMed ID: 37652681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Characteristics and Outcomes of Children With SARS-CoV-2 Infection During the Delta and Omicron Variant-Dominant Periods in Korea.
    Choi SH; Choi JH; Lee JK; Eun BW; Song SH; Ahn B; Kim YK; Yun KW
    J Korean Med Sci; 2023 Mar; 38(9):e65. PubMed ID: 36880106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccine Effect on Household Transmission of Omicron and Delta SARS-CoV-2 Variants.
    Kim YC; Kim B; Son NH; Heo N; Nam Y; Shin A; Yang AJ; Kim MH; Kyong T; Kang E; Park YS; Kim H
    J Korean Med Sci; 2023 Jan; 38(1):e9. PubMed ID: 36593690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of clinical characteristics and outcomes of critically ill adults with SARS-CoV-2 infection during Delta and Omicron variant predominance periods: a single-hospital retrospective cohort study.
    Sankar K; Modi N; Polyak A; Directo MP; Johnson LR; Kho N; Isonaka SK; Pedraza I; Chen P; Modes ME
    BMJ Open Respir Res; 2023 Feb; 10(1):. PubMed ID: 36805880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.
    Modes ME; Directo MP; Melgar M; Johnson LR; Yang H; Chaudhary P; Bartolini S; Kho N; Noble PW; Isonaka S; Chen P
    MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):217-223. PubMed ID: 35143466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 Secondary Attack Rates in Vaccinated and Unvaccinated Household Contacts during Replacement of Delta with Omicron Variant, Spain.
    López-Muñoz I; Torrella A; Pérez-Quílez O; Castillo-Zuza A; Martró E; Bordoy AE; Saludes V; Blanco I; Soldevila L; Estrada O; Valerio L; Roure S; Vallès X
    Emerg Infect Dis; 2022 Oct; 28(10):1999-2008. PubMed ID: 36037811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.
    Gram MA; Emborg HD; Schelde AB; Friis NU; Nielsen KF; Moustsen-Helms IR; Legarth R; Lam JUH; Chaine M; Malik AZ; Rasmussen M; Fonager J; Sieber RN; Stegger M; Ethelberg S; Valentiner-Branth P; Hansen CH
    PLoS Med; 2022 Sep; 19(9):e1003992. PubMed ID: 36048766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal and perinatal outcomes of SARS-CoV-2 infection in unvaccinated pregnancies during Delta and Omicron waves.
    Birol Ilter P; Prasad S; Mutlu MA; Tekin AB; O'Brien P; von Dadelszen P; Magee LA; Tekin S; Tug N; Kalafat E; Khalil A
    Ultrasound Obstet Gynecol; 2022 Jul; 60(1):96-102. PubMed ID: 35441407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Quick Displacement of the SARS-CoV-2 variant Delta with Omicron: Unprecedented Spike in COVID-19 Cases Associated with Fewer Admissions and Comparable Upper Respiratory Viral Loads.
    Fall A; Eldesouki RE; Sachithanandham J; Morris CP; Norton JM; Gaston DC; Forman M; Abdullah O; Gallagher N; Li M; Swanson NJ; Pekosz A; Klein EY; Mostafa HH
    medRxiv; 2022 Jan; ():. PubMed ID: 35118480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.
    Accorsi EK; Britton A; Fleming-Dutra KE; Smith ZR; Shang N; Derado G; Miller J; Schrag SJ; Verani JR
    JAMA; 2022 Feb; 327(7):639-651. PubMed ID: 35060999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal and perinatal outcomes following pre-Delta, Delta, and Omicron SARS-CoV-2 variants infection among unvaccinated pregnant women in France and Switzerland: a prospective cohort study using the COVI-PREG registry.
    Favre G; Maisonneuve E; Pomar L; Daire C; Poncelet C; Quibel T; Monod C; Martinez de Tejada B; Schäffer L; Papadia A; Radan AP; Todesco-Bernasconi M; Ville Y; Voekt CA; Eggel-Hort B; Capoccia-Brugger R; Johann S; Grawe C; Defert S; Mottet N; Kahlert CR; Garabedian C; Sentilhes L; Weber B; Leu S; Bassler D; Lepigeon K; Winterfeld U; Panchaud A; Baud D;
    Lancet Reg Health Eur; 2023 Mar; 26():100569. PubMed ID: 36628358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Delta Variant and Vaccination on SARS-CoV-2 Secondary Attack Rate Among Household Close Contacts.
    Ng OT; Koh V; Chiew CJ; Marimuthu K; Thevasagayam NM; Mak TM; Chua JK; Ong SSH; Lim YK; Ferdous Z; Johari AKB; Chen MI; Maurer-Stroh S; Cui L; Lin RTP; Tan KB; Cook AR; Leo PY; Lee PVJ
    Lancet Reg Health West Pac; 2021 Dec; 17():100299. PubMed ID: 34746899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study.
    Nielsen KF; Moustsen-Helms IR; Schelde AB; Gram MA; Emborg HD; Nielsen J; Hansen CH; Andersen MA; Meaidi M; Wohlfahrt J; Valentiner-Branth P
    PLoS Med; 2022 Nov; 19(11):e1004037. PubMed ID: 36413551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Secondary Attack Rates among the Household Contacts of Patients with the Omicron Variant of the Coronavirus Disease 2019 in Japan.
    Ogata T; Tanaka H; Tanaka E; Osaki N; Noguchi E; Osaki Y; Tono A; Wada K
    Int J Environ Res Public Health; 2022 Jun; 19(13):. PubMed ID: 35805724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative severity of COVID-19 cases caused by Alpha, Delta or Omicron SARS-CoV-2 variants and its association with vaccination].
    Varea-Jiménez E; Cano EA; Vega-Piris L; Sánchez EVM; Mazagatos C; Rodríguez-Alarcón LGSM; Casas I; Moros MJS; Iglesias-Caballero M; Vazquez-Morón S; Larrauri A; Monge S
    Enferm Infecc Microbiol Clin; 2022 Dec; ():. PubMed ID: 36506460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Household Secondary Attack Rates of SARS-CoV-2 Omicron Variant, South Korea, February 2022.
    Lim DS; Choe YJ; Man Kim Y; Lee SE; Jang EJ; Kim J; Park YJ
    Emerg Infect Dis; 2022 Aug; 28(8):1731-1734. PubMed ID: 35798007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Household Secondary Attack Rates of SARS-CoV-2 by Variant and Vaccination Status: An Updated Systematic Review and Meta-analysis.
    Madewell ZJ; Yang Y; Longini IM; Halloran ME; Dean NE
    JAMA Netw Open; 2022 Apr; 5(4):e229317. PubMed ID: 35482308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse outcomes of SARS-CoV-2 infection with delta and omicron variants in vaccinated versus unvaccinated US veterans: retrospective cohort study.
    Bohnert AS; Kumbier K; Rowneki M; Gupta A; Bajema K; Hynes DM; Viglianti E; O'Hare AM; Osborne T; Boyko EJ; Young-Xu Y; Iwashyna TJ; Maciejewski M; Schildhouse R; Dimcheff D; Ioannou GN
    BMJ; 2023 May; 381():e074521. PubMed ID: 37220941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased household transmission and immune escape of the SARS-CoV-2 Omicron compared to Delta variants.
    Jalali N; Brustad HK; Frigessi A; MacDonald EA; Meijerink H; Feruglio SL; Nygård KM; Rø G; Madslien EH; de Blasio BF
    Nat Commun; 2022 Sep; 13(1):5706. PubMed ID: 36175424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding SARS-CoV-2 Delta and Omicron variant transmission and vaccine impact in schools and child-care settings in Australia: a population-based study.
    Koirala A; Winkler NE; Quinn HE; Gardiner E; Liu B; Forbes J; Sharpe C; van Tussenbroek T; Wood N; Macartney K
    Lancet Reg Health West Pac; 2023 Jun; 35():100736. PubMed ID: 37360872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.